FGF-23
Selected indexed studies
- FGF-23 as a Biomarker for Carotid Plaque Vulnerability: A Systematic Review. (Med Sci (Basel), 2025) [PMID:40137447]
- Phosphate and FGF-23. (Kidney Int Suppl, 2011) [PMID:21346724]
- FGF-23 and cardiovascular disease: review of literature. (Curr Opin Endocrinol Diabetes Obes, 2016) [PMID:27652999]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- FGF-23 as a Biomarker for Carotid Plaque Vulnerability: A Systematic Review. (2025) pubmed
- Phosphate and FGF-23. (2011) pubmed
- FGF-23 and cardiovascular disease: review of literature. (2016) pubmed
- FGF-23 in bone biology. (2010) pubmed
- FGF-23: state of the art. (2010) pubmed
- FGF-23 and secondary hyperparathyroidism in chronic kidney disease. (2013) pubmed
- FGF-23 from erythroblasts promotes hematopoietic progenitor mobilization. (2021) pubmed
- FGF-23 and sclerostin in serum and bone of CKD patients. (2023) pubmed
- Phosphate and FGF-23 homeostasis after kidney transplantation. (2015) pubmed
- Anemia and Mineral Bone Disorder in Kidney Disease Patients: The Role of FGF-23 and Other Related Factors. (2024) pubmed